GoKawiil
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
(feeds.content.dowjones.io)
1.
2.
Opinion | The Lawsuits Will Continue Until Morale Improves
(feeds.content.dowjones.io)
3.
UCB to Buy Candid Therapeutics for Up to $2.2 Billion
(feeds.content.dowjones.io)
5.
Improving access to essential medicines via decision-aware machine learning
(feeds.nature.com)
6.
Why has there been so little progress on Alzheimer's disease?
(news.ycombinator.com)
7.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
9.
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion
(feeds.content.dowjones.io)
10.
Eye drops made from pig semen deliver cancer treatment to mice
(feeds.nature.com)
11.
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets
(feeds.content.dowjones.io)
12.
Scientists discover a surprising way to quiet the anxious mind (2025)
(news.ycombinator.com)
13.
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
(feeds.nature.com)
14.
Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar
(feeds.content.dowjones.io)
15.
Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products
(feeds.content.dowjones.io)
16.
17.
Time to End Roundtripping by Big Pharma
(news.ycombinator.com)
18.
The Day Novartis Chose Discovery
(news.ycombinator.com)